The Leadership Team at AffyImmune Therapeutics is responsible for strategic decision-making, overseeing clinical trials, securing funding, and steering the company towards its mission of developing safe and effective CAR T cell therapies for solid cancers. Through their expertise and leadership, they guide the company in scientific innovation and operational excellence.
View all